梅州无痛人流医院(梅州二个月打胎要多少钱) (今日更新中)

WASHINGTON, March 25 (Xinhua) -- Researchers at the University of Colorado (CU) and the Harvard University have found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others, according to a study published this week in the Journal of Epidemiology and Community Health.They spent four years analyzing death certificates from every county in the United States. They examined cause-of-death, socio- economic factors and other issues in their research.They found that of the top 20 counties with the highest life expectancy, eleven for men and five for women were located in Colorado and Utah. And each county was at a mean elevation of 5, 967 feet above sea level. The men lived between 75.8 and 78.2 years, while women ranged from 80.5 to 82.5 years.Compared to those living near sea-level, the men lived 1.2 to 3. 6 years longer and women 0.5 to 2.5 years more."If living in a lower oxygen environment such as in our Colorado mountains helps reduce the risk of dying from heart disease it could help us develop new clinical treatments for those conditions," said Benjamin Honigman, professor of Emergency Medicine at the CU School of Medicine. "Lower oxygen levels turn on certain genes and we think those genes may change the way heart muscles function. They may also produce new blood vessels that create new highways for blood flow into the heart."Another explanation, he said, could be that increased solar radiation at altitude helps the body better synthesize vitamin D which has also been shown to have beneficial effects on the heart and some kinds of cancer.Despite these numbers, the study showed that when socio- economic factors, solar radiation, smoking and pulmonary disease were taken into account, the net effect of altitude on overall life expectancy was negligible.Still, Honigman said, altitude seems to offer protection against heart disease deaths and may also play a role in cancer development.Colorado, the highest state in the nation, is also the leanest state, the fittest state, has the fewest deaths from heart disease and a lower incidence of colon and lung cancer compared to others.

WELLINGTON, May 27 (Xinhua) -- Eating kiwifruit might be a much better way of getting vitamin C into your system than taking purified vitamin supplements, according to research from New Zealand.Researchers with the University of Otago found that in mice eating kiwifruit, vitamin C uptake was five times as effective as taking a purified supplement form.The study was published in the American Journal of Clinical Nutrition, the highest ranking journal for human nutrition research, said a statement from the university.Lead researcher Associate Professor Margreet Vissers said people required vitamin C (ascorbate) in all body tissues and organs to be healthy, but the only source of vitamin C was through food or in purified form, arguably the most commonly consumed vitamin supplement.In the experiment vitamin C-deficient mice were fed the vitamin over a month, either as kiwifruit or as an equivalent amount of pure vitamin C, said the statement.Mice fed the kiwifruit absorbed vitamin C much more efficiently than those given the purified supplement form, and they also retained it for longer, indicating something in the fruit improved absorption and retention."The findings of the mouse trial have important implications for human nutrition," said Vissers."The question that has often been asked is whether a supplement is as good a source of vitamin C as whole foods, but few studies have addressed this issue. We are uniquely placed to do that work. "An equivalent human study was underway to determine whether the situation also applied to people, said the statement.The mouse study was funded by the university and kiwifruit marketing firm Zespri.

CANBERRA, May 10 (Xinhua) -- Technology may have a harmful effect on children's development and creativity, Australia's report found on Tuesday.The Pilot Pen Australia Creativity Report found that children could be depending too much on technology such as computers.Written by psychologist Kimberley O'Brien, the report suggested that students are becoming scared of handwritten tasks as there is no spelling or grammar check tool to pick up their mistakes as they go along."Children who develop this kind of dependency on computer software are less likely to write using a pen and paper given that they will feel a vulnerability to failure," the report said.It said using software that immediately tells children to correct errors like spelling and grammar could disrupts their thought patterns and stunts their ideas, and children who hand write are able to produce almost twice as many ideas as those using computer technology to write a creative story.The report studied 300 Year five and six children, and found handwritten essays were completed significantly faster and contained a higher standard of sentence structure, grammar, punctuation, cohesion, ideas development and organization than those completed using keyboards.A further study found students in Years two, four and six produced up to twice as many ideas writing on pen and paper as those on computers.O'Brien said the results were due to computers putting extra pressure on writers to edit as they go rather than get their ideas down first and edit minor mistakes later.O'Brien said children were most likely to develop their handwriting skills between the ages of eight and 10, and she urged all teachers and parents to ensure their children met community standards for legible handwriting.However, she said that computers are a good support tool, and they should not replace handwriting entirely.

BEIJING, Feb. 26 (Xinhua) -- China's Ministry of Education said Friday that 34.29 million students graduated from the country's higher-learning institutions between 2006 and 2010.Xu Mei, the ministry's spokeswoman, said the number is even more than that of the graduates in the 20 years prior to 2006 combined."During the 11th five-year plan period (2006-2010), higher education has become even more accessible to the general public. Higher-learning institutions provide a strong support of brain power and human resources to the social and economic development," Xu said.The "Outline of China's National Plan for Medium and Long-Term Education Reform and Development (2010-2020)," which was publicized last year, says "the strategic goals to be attained by 2020 are to basically modernize education; shape a learning society; and turn China into a country rich in human resources."

WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.

来源：资阳报